Atlas Trials

Exploratory Study to Investigate the Reparative and Regenerative Potential of Alemtuzumab in Relapsing-Remitting Multiple Sclerosis Patients Participating in the CARE MS I and MS II Studies

Clinical trial NCT01020370 · COMPLETED

Trial details

NCT number
NCT01020370
Sponsor
Wayne State University
Status
COMPLETED
Study type
OBSERVATIONAL
Multiple Sclerosis

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.